WFDC2 and ovarian carcinoma: Recently HE4 (cut-off 70 pmol/L) has been shown to be a promising marker, still under investigation, alone or in combination with CA-125, for ovarian cancers follow-up, showing 76.47% sensitivity and 100% specificity [14,15].